Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.

by Jérôme Durussel, Evangelia Daskalaki, Martin Anderson, Tushar Chatterji, Diresibachew H Wondimu, Neal Padmanabhan, Rajan K Patel, John D McClure, Yannis P Pitsiladis
Published 2013-01-01

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration

by Guan Wang, Jérôme Durussel, Jonathan Shurlock, Martin Mooses, Noriyuki Fuku, Georgie Bruinvels, Charles Pedlar, Richard Burden, Andrew Murray, Brendan Yee, Anne Keenan, John D. McClure, Pierre-Edouard Sottas, Yannis P. Pitsiladis
Published 2017-11-01

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial.

by Adam Kurkiewicz, Anneli Cooper, Emily McIlwaine, Sarah A Cumming, Berit Adam, Ralf Krahe, Jack Puymirat, Benedikt Schoser, Lubov Timchenko, Tetsuo Ashizawa, Charles A Thornton, Simon Rogers, John D McClure, Darren G Monckton
Published 2020-01-01